大型肝細胞癌に対するレシチン加リピオドールエマルジョンを用いた肝動脈塞栓術の有用性

小林 慎二郎; 大坪 毅人; 小泉 哲; 吉利 賢治; 片桐 聡; 古川 達也; 山本 雅一; 高崎 健

doi:10.11405/nisshoshi.104.1601

Original article

Usefulness of transcatheter arterial embolization (TAE) for large hepatocellular carcinoma using a lecithin-added Lipiodol emulsion

Shinjiro KOBAYASHI, Takehito OTSUBO, Satoshi KOIZUMI, Kenji YOSHITOSHI, Satoshi KATAGIRI, Tatsuya FURUKAWA, Masakazu YAMAMOTO, Ken TAKASAKI

Author information

Shinjiro KOBAYASHI
Department of Surgery, Institute of Gastroenterology, Tokyo Women's Medical University (Tokyo)
Takehito OTSUBO
Department of Surgery, Institute of Gastroenterology, St Marianna University of Medicine (Kanagawa)
Satoshi KOIZUMI
Department of Surgery, Institute of Gastroenterology, Tokyo Women's Medical University (Tokyo)
Kenji YOSHITOSHI
Department of Surgery, Institute of Gastroenterology, Tokyo Women's Medical University (Tokyo)
Satoshi KATAGIRI
Department of Surgery, Institute of Gastroenterology, Tokyo Women's Medical University (Tokyo)
Tatsuya FURUKAWA
Department of Surgery, Institute of Gastroenterology, Tokyo Women's Medical University (Tokyo)
Masakazu YAMAMOTO
Department of Surgery, Institute of Gastroenterology, Tokyo Women's Medical University (Tokyo)
Ken TAKASAKI
Department of Surgery, Institute of Gastroenterology, Tokyo Women's Medical University (Tokyo)

JOURNAL FREE ACCESS

2007 Volume 104 Issue 11 Pages 1601-1606

DOI https://doi.org/10.11405/nisshoshi.104.1601

Details

Abstract

This study was to retrospectively compare the effectiveness of transarterial embolization (TAE) using a lipidol emulsion for large lesion of hepatocellular carcinoma (HCC). average survival time was retrospectively compared in patients with HCC larger then 3 cm in diameter. Twenty patients were treated with conventional transarterial embolization (TAE)(group A), 27 with transarterial embolization using a lipidol emulsion (TAE-L) (group B). Rates of effectiveness at 3 months and 6 months following treatment were 10.0% and 5.0% in group A and 37.0 and 33.3% in group B respectively (P=0.046, 0.029). The median survival times were 12.0 months in Group A and 23.0 months in Group B (P=0.049).

Corresponding author

Register with J-STAGE for free!